Morita T, Tsuruzono Y, Ueki H
Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Japan.
Chem Pharm Bull (Tokyo). 1991 Sep;39(9):2449-50. doi: 10.1248/cpb.39.2449.
A protein kinase inhibitor, 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H-7) increased lipoprotein lipase (LPL) activity in isolated rat fat pads in a time- and dose-dependent manner. The incubation of H-7 with partially purified LPL did not affect its activity. Under the marked inhibition of protein synthesis by cycloheximide, H-7 still showed a full effect on the increase in LPL activity. A slight but significant increase in LPL activity in the fat pads was observed with inhibitors of cyclic nucleotide-dependent protein kinase. H-7, therefore, may increase LPL activity through processes other than the direct activation of the LPL molecule, or the stimulation of LPL molecule synthesis; probably through a decrease in the activity of protein kinases, especially protein kinase C.
一种蛋白激酶抑制剂,1-(5-异喹啉磺酰基)-2-甲基哌嗪(H-7)以时间和剂量依赖的方式增加了分离的大鼠脂肪垫中的脂蛋白脂肪酶(LPL)活性。H-7与部分纯化的LPL孵育并不影响其活性。在环己酰亚胺对蛋白质合成有明显抑制作用的情况下,H-7对LPL活性的增加仍显示出完全的作用效果。用环核苷酸依赖性蛋白激酶抑制剂时,观察到脂肪垫中LPL活性有轻微但显著的增加。因此,H-7可能通过直接激活LPL分子或刺激LPL分子合成以外的过程来增加LPL活性;可能是通过降低蛋白激酶尤其是蛋白激酶C的活性来实现的。